Cervical Dystonia Market is segmented By Treatment Type (Botulinum Toxin Injections, Oral Medication...
Market Size in USD Mn
CAGR6.2%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 6.2% |
Market Concentration | High |
Major Players | Allergan plc, Ipsen Pharma, Merz Pharma GmbH & Co. KGaA, Lundbeck A/S, Revance Therapeutics, Inc. and Among Others |
The cervical dystonia market is estimated to be valued at USD 281.5 Mn in 2025 and is expected to reach USD 428.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2032. Cervical dystonia is a neurological movement disorder characterized by involuntary muscle contractions in the neck and acute to moderate chronic pain, leading to aberrant head positioning or Turnbulls' disease.